# 510(k) Summary COULTER® LH 780 Hematology Analyzer

# 1.0 Submitted By:

Nancy Nadler   
Staff Regulatory Affairs Specialist Beckman Coulter, Inc.   
11800 SW 147 Avenue, M/C: 31-B06 Miami, Florida 33196-2500   
Telephone: (305) 380-4191   
FAX: (305) 380-3618

# 2.0 Date Submitted:

June 8, 2006

# 3.0 Device Name(s):

# 3.1 Proprietary Names

COULTER® LH 780 Hematology Analyzer

# 3.2 Classification Name

Automated differential cell counter (21 CFR $\ S$ 864.5220)

# 4.0 Predicate Devices:

<table><tr><td>Candidate</td><td>Predicates</td><td>Manufacturer</td><td>Docket Number</td></tr><tr><td rowspan="3">COULTER LH 780 Hematology Analyzer</td><td>COULTER® LH 750 Hematology Analyzer</td><td>Beckman Coulter, Inc.</td><td>K011342</td></tr><tr><td>COULTER LH 750 Body Fluids Application (for Body Fluids equivalence only)</td><td>Beckman Coulter, Inc.</td><td>K030606</td></tr><tr><td>Sysmex™ Automated Hematology Analyzer XE-2100 (for RDW SD Parameter equivalence only)</td><td>Sysmex Corporation</td><td>K992875</td></tr></table>

Beckman Coulter , Inc. 11800 S.W. 147th Avenue Miami, FL 33196-2500

Mailing Address: 11800 S.W. 147th Avenue P.O. Box 169015 Miami, FL 33116-9015

Customer Service: (800) 526-7694 Product Information: (800) 526-6932 (800) 327-6531 (305) 380-3800 Internet: www.beckmancoulter.com

# 5.0 Description:

The COULTER LH 780 Hematology Analyzer is designed For In Vitro Diagnostic Use in clinical laboratories. The LH 780 provides automated complete blood count, leukocyte differential, NRBC enumeration and reticulocyte analysis as well as an automated method for enumeration of RBCs and WBCs in body fluids

The purpose of the LH 780 Hematology Analyzer is to separate the normal patient, with all normal system-generated parameters, from the patient who needs additional studies of any of these parameters. These studies might include further measurements of cell size and platelet distribution, manual WBC differential or any other definitive test that helps diagnose the patient's condition.

The instrument system is comprised of the analyzer and a suite of analytical reagents that allow for simultaneous quantitative determination of hemoglobin measurement, cell counting and sizing, reticulocyte determination, quality control, calibration and cleaning.

# 6.0 Intended Use:

The COULTER LH 780 Hematology Analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter For In Vitro Diagnostic Use in clinical laboratories. The COULTER LH 780 Hematology Analyzer provides automated Reticulocyte analysis and enumeration of nucleated red blood cells (NRBCs) as well as an automated method for enumeration of RBCs and WBCs in body fluids.

# 7.0 Comparison to Predicate(s):

<table><tr><td rowspan=1 colspan=1>Charactersie</td><td rowspan=1 colspan=1>SV COULTER LH 750 (Predicate)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The COULTER LH 750 Hematology Analyzer is a quantitative,automated hematology analyzer and leukocyte differentialcounter For In Vitro Diagnostic Use in clinical laboratories. TheCOULTER LH 750 Hematology Analyzer provides automatedReticulocyte analysis and enumeration of nucleated red bloodcells (NRBCs) as well as an automated method for enumerationof RBCs and WBCs in body fluids.</td><td rowspan=1 colspan=1>Same as LH 750except referring to the LH 780</td></tr><tr><td rowspan=1 colspan=1>Parameters IVD</td><td rowspan=1 colspan=1>WBC, RBC, Hgb, Hct, MCV, MCH, MCHC, RDW, PIt, MPV, LY%,MO%, NE%, EO%, BA%, LY#, MO#, NE#, EO#, BA#, NRBC%,NRBC#, RET%, RET#, IRF, &amp; MRV.</td><td rowspan=1 colspan=1>Same as LH 750 plusRDW-SD</td></tr><tr><td rowspan=1 colspan=1>Quality ControlTechniques</td><td rowspan=1 colspan=1>Daily Instruments Check, Commercial Controls, Delta Checks,Patient Controls, XB Analysis, &amp; IQAP.</td><td rowspan=1 colspan=1>Same as LH 750 plusExtended QC &amp; XM Analysis</td></tr><tr><td rowspan=1 colspan=1>Quality Controls &amp;Calibrator</td><td rowspan=1 colspan=1>COULTER® 5C® Cell ControlCOULTER® Latron™™ Primer and Latron ControlCOULTER® RETIC-CTM Cell ControlCOULTER® LIN-C® linearity controlCOULTER S-CAL® calibrator kit</td><td rowspan=1 colspan=1>Same as LH 750</td></tr></table>

<table><tr><td>COULTER LH 750 (Predicate) COULTER LH 780 Characteristic</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Analysis Reagents</td><td rowspan=1 colspan=1>COULTER LH Series DiluentCOULTER® Isoton 4 DiluentCOULTER® LH Series PakCOULTER® LH Series RETIC PakCOULTER® Lyse S® 1II lytic agentCOULTER® Lyse S® 4 lytic agent</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Cleaning Agent</td><td rowspan=1 colspan=1>COULTER@ CLENZ</td><td rowspan=1 colspan=1>Same as LH 750 plusCOULTER® LH Series Cleaner</td></tr><tr><td rowspan=2 colspan=1>New Features(not covered above)</td><td rowspan=2 colspan=1>n/a</td><td></td></tr><tr><td rowspan=1 colspan=1>RBC correctionGraphical representation ofcustomer-definable high / lowlimits on the RBC histogramAdvanced bar-code readerControl folder filtersReproducibility and carryover notrequired as pre-calibrationchecks</td></tr></table>

# 8.0 Summary of Performance Data:

Accuracy, precision, linearity and carryover studies were conducted and demonstrated acceptable performance per the manufacturer specifications. The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to products already in commercial distribution.

This summary of safety and effectiveness is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and the implementing regulation 21 CFR 807.92.

<table><tr><td rowspan=1 colspan=1>Characterisic</td><td rowspan=1 colspan=2>cOULTERLH750 (Predicate)</td><td rowspan=1 colspan=1>COULTERLH 780</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=2>The COULTER LH 750 Hematology Analyzer is a quantitative,automated hematology analyzer and leukocyte differentialcounter For In Vitro Diagnostic Use in clinical laboratories. TheCOULTER LH 750 Hematology Analyzer provides automatedReticulocyte analysis and enumeration of nucleated red bloodcells (NRBCs) as well as an automated method for enumerationof RBCs and WBCs in body fluids.</td><td rowspan=1 colspan=1>Same as LH 750except referring to the LH 780</td></tr><tr><td rowspan=1 colspan=1>Indication For Use</td><td rowspan=1 colspan=2>The purpose of the LH 700 Series is to separate the normalpatient, with all normal system-generated parameters, from thepatient who needs additional studies of any of these parameters.These studies might include further measurements of cell sizeand platelet distribution, manual WBC differential or any otherdefinitive test that helps diagnose the patient&#x27;s condition.</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Parameters IVD</td><td rowspan=1 colspan=2>WBC, RBC, Hgb, Hct, MCV, MCH, MCHC, RDW, PIt, MPV, LY%,MO%, NE%, EO%, BA%, LY#, MO#, NE#, EO#, BA#, NRBC%,NRBC#, RET%, RET#, IRF, &amp; MRV.</td><td rowspan=1 colspan=1>Same as LH 750 plusRDW-SD</td></tr><tr><td rowspan=1 colspan=1>Quality ControlTechniques</td><td rowspan=1 colspan=2>Daily Instruments Check, Commercial Controls, Delta Checks,Patient Controls, XB Analysis, &amp; IQAP.</td><td rowspan=1 colspan=1>Same as LH 750 plusExtended QC &amp; XM Analysis</td></tr><tr><td rowspan=1 colspan=1>Method History</td><td rowspan=1 colspan=2>Coulter Principle, Hemoglobinometry, VCS technology, &amp; NRBCenumeration.</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Quality Controls &amp;Calibrator</td><td></td><td rowspan=1 colspan=1>COULTER® 5C® Cell ControlCOULTER@ LatronTM Primer and Latron ControlCOULTER® RETIC-CTM Cell ControlCOULTER@ LIN-C® linearity controlCOULTER® S-CAL® calibrator kit</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Analysis Reagents</td><td></td><td rowspan=1 colspan=1>COULTER® LH Series DiluentCOULTER® Isoton 4 DiluentCOULTER® LH Series PakCOULTER@ LH Series RETIC PakCOULTER® Lyse S® III lytic agentCOULTER® Lyse S® 4 lytic agent</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Cleaning Agent</td><td></td><td rowspan=1 colspan=1>COULTER® CLENZ</td><td rowspan=1 colspan=1>Same as LH 750 plusCOULTER® LH Series Cleaner</td></tr><tr><td rowspan=1 colspan=1>PerformanceSpecifications</td><td></td><td rowspan=1 colspan=1>Within-Run precision (CBC, Diff, Retic),Accuracy(CBC, Diff, Retic), Linearity (WBC, RBC, Hgb, &amp; PIt).Background (WBC, RBC, Hgb, &amp; PIt),Operating and Reportable Ranges (CBC, Diff, Retic, NRBC), &amp;Mode to Mode Comparison (WBC, RBC, Hgb, PIt).</td><td rowspan=1 colspan=1>Same as LH750 plusWithin-Run precision, Accuracy, andOperating and Reportable Rangesinclude RDW-SD and a tighter WBCLinearity specification</td></tr><tr><td rowspan=1 colspan=1>Service diagnostics</td><td></td><td rowspan=1 colspan=1>Uses ProService Remote Diagnostics</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Hardware Options</td><td></td><td rowspan=1 colspan=1>Graphic/Laser Printer, LH 700 Series SlideMaker, &amp; LH 700Series SlideStainer.</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Uncorrected WBC(UWBC)</td><td></td><td rowspan=1 colspan=1>Result reported in a comment field</td><td rowspan=1 colspan=1>Result reported in parameter block</td></tr></table>

Parameters (con't):   

<table><tr><td rowspan=1 colspan=1>NE%</td><td rowspan=1 colspan=1>Neutrophil percent</td></tr><tr><td rowspan=1 colspan=1>E0%</td><td rowspan=1 colspan=1>Eosinophil percent</td></tr><tr><td rowspan=1 colspan=1>BA%</td><td rowspan=1 colspan=1>Basophil percent</td></tr><tr><td rowspan=1 colspan=1>LY#</td><td rowspan=1 colspan=1>Lymphocyte number</td></tr><tr><td rowspan=1 colspan=1>MO#</td><td rowspan=1 colspan=1>Monocyte number</td></tr><tr><td rowspan=1 colspan=1>NE#</td><td rowspan=1 colspan=1>Neutrophil number</td></tr><tr><td rowspan=1 colspan=1>EO#</td><td rowspan=1 colspan=1>Eosinophil number</td></tr><tr><td rowspan=1 colspan=1>BA#</td><td rowspan=1 colspan=1>Basophil number</td></tr><tr><td rowspan=1 colspan=1>NRBC%</td><td rowspan=1 colspan=1>Nucleated Red Blood Cell percent</td></tr><tr><td rowspan=1 colspan=1>NRBC#</td><td rowspan=1 colspan=1>Nucleated Red Blood Cell number</td></tr><tr><td rowspan=1 colspan=1>RET%</td><td rowspan=1 colspan=1>Reticulocyte percent</td></tr><tr><td rowspan=1 colspan=1>RET#</td><td rowspan=1 colspan=1>Reticulocyte number</td></tr><tr><td rowspan=1 colspan=1>IRF</td><td rowspan=1 colspan=1>Immature Reticulocyte Fraction</td></tr><tr><td rowspan=1 colspan=1>MRV</td><td rowspan=1 colspan=1>Mean Reticulocyte Volume</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Characterlstic</td><td rowspan=1 colspan=1>CCOULTER LH 750 (Predicate)</td><td rowspan=1 colspan=1>COULTER LH 780</td></tr><tr><td rowspan=1 colspan=1>Parameters IVD</td><td rowspan=1 colspan=1>WBC, RBC, Hgb, Hct, MCV, MCH, MCHC, RDW, PIt, MPV, LY%,MO%, NE%, EO%, BA%, LY#, MO#, NE#, EO#, BA#, NRBC%,NRBC#, RET%, RET#, IRF, &amp; MRV.</td><td rowspan=1 colspan=1>Same as LH 750 plusRDW-SD</td></tr><tr><td rowspan=1 colspan=1>Quality ControlTechniques</td><td rowspan=1 colspan=1>Daily Instruments Check, Commercial Controls, Delta Checks,Patient Controls, XB Analysis, &amp; IQAP.</td><td rowspan=1 colspan=1>Same as LH 750 plusExtended QC &amp; XM Analysis</td></tr><tr><td rowspan=1 colspan=1>Method History</td><td rowspan=1 colspan=1>Coulter Principle, Hemoglobinometry, VCS technology, &amp; NRBCenumeration.</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Quality Controls &amp;Calibrator</td><td rowspan=1 colspan=1>COULTER® 5C® Cell ControlCOULTER® Latron™M Primer and Latron ControlCOULTER® RETIC-C™M Cell ControlCOULTER LIN-C® linearity controlCOULTER® S-CAL® calibrator kit</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Analysis Reagents</td><td rowspan=1 colspan=1>COULTER® LH Series DiluentCOULTER® Isoton 4 DiluentCOULTER@ LH Series PakCOULTER® LH Series RETIC PakCOULTER@ Lyse S II lytic agentCOULTER® Lyse S® 4 lytic agent</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Cleaning Agent</td><td rowspan=1 colspan=1>COULTERO CLENZ</td><td rowspan=1 colspan=1>Same as LH 750 plusCOULTER® LH Series Cleaner</td></tr><tr><td rowspan=1 colspan=1>PerformanceSpecifications</td><td rowspan=1 colspan=1>Within-Run precision (CBC, Diff, Retic),Accuracy(CBC, Diff, Retic), Linearity (WBC, RBC, Hgb, &amp; PIt),Background (WBC, RBC, Hgb, &amp; PIt),Operating and Reportable Ranges (CBC, Diff, Retic, NRBC), &amp;Mode to Mode Comparison (WBC, RBC, Hgb, PIt).</td><td rowspan=1 colspan=1>Same as LH750 plusWithin-Run precision, Accuracy, andOperating and Reportable Rangesinclude RDW-SD and a tighter WBCLinearity specification</td></tr><tr><td rowspan=1 colspan=1>Service diagnostics</td><td rowspan=1 colspan=1>Uses ProService Remote Diagnostics</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Hardware Options</td><td rowspan=1 colspan=1>Graphic/Laser Printer, LH 700 Series SlideMaker, &amp; LH 700Series SlideStainer.</td><td rowspan=1 colspan=1>Same as LH 750</td></tr><tr><td rowspan=1 colspan=1>Uncorrected WBC(UWBC)</td><td rowspan=1 colspan=1>Result reported in a comment field</td><td rowspan=1 colspan=1>Result reported in parameter block</td></tr><tr><td rowspan=1 colspan=1>New Features(not covered above)</td><td rowspan=1 colspan=1>n/a</td><td rowspan=1 colspan=1>RBC correctionGraphical representation ofcustomer-definable high / lowlimits on the RBC histogramAdvanced bar-code readerControl folder filtersReproducibility and carryover notrequired as pre-calibrationchecks</td></tr></table>

Ms. Nancy Nadler   
Staff Regulatory Affairs Specialist Beckman Coulter, Inc.   
11800 S.W. 147 Avenue   
M/S 31-B06   
Miami, Florida 33196-2500

OCY - 4 2006

Re: k061616 Trade/Device Name: COULTER® LH 780 Hematology Analyzer Regulation Number: 21 CFR $\$ 864.5220$ EY Regulation Name: Automated differential cell counter Regulatory Class: II Product Code: GKZ Dated: September 20, 2006 Received: September 21. 2006

Dear Ms. Nadler:

We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

Page 2 -

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html

Sincerely yours,

![](images/6b7209b0517da503a535e8d6128a7f650b629c4a62500d7671be61ad2286590f.jpg)

Robert L. Becker, Jr., MD, PRD   
Director   
Division of Immunology and Hematology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

# Indications for Use

510(k) Number (if known): $K O \varphi ( C ) \cup D C$

# Device Name: COULTER® LH 780 Hematology Analyzer

Indications For Use: The COULTER LH 780 Hematology Analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter For In Vitro Diagnostic Use in clinical laboratories. The COULTER LH 780 Hematology Analyzer provides automated Reticulocyte analysis and enumeration of nucleated red blood cells (NRBCs) as well as an automated method for enumeration of RBCs and WBCs in body fluids.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/564b2ede629da3db06e9ec99c95788a46475043d42ef6f4643d0921b1977b58e.jpg)  
Page 1 of 1